第1笔成交价格为83.15元，成交5.00万股，成交金额415.75万元，溢价率为-3.00%，买方营业部为东兴 证券股份有限公司成都都江堰市彩虹大道证券营业部，卖方营业部为中国银河证券股份有限公司北京金 融街证券营业部。 进一步统计，近3个月内该股累计发生3笔大宗交易，合计成交金额为1702.25万元。该股近5个交易日累 计下跌2.15%，主力资金合计净流出1055.84万元。 责任编辑：小浪快报 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 1月19日，博苑股份收跌2.10%，收盘价为85.72元，发生1笔大宗交易，合计成交量5万股，成交金额 415.75万元。 ...

Core Viewpoint - The company is focusing on the application of iodides in the perovskite field and has initiated technical research and product development in this area, with ongoing projects but no product sales yet [1] Company Overview - The company, Boyuan Co., Ltd. (301617), has a current iodide production capacity of 4,100 tons per year [1] - There is an additional project in the trial production phase with a capacity of 4,000 tons per year [1]

Core Viewpoint - The company is focusing on the application of iodides in the perovskite field and has initiated technical research and product development in this area, with ongoing projects but no product sales yet [1] Group 1 - The company has an existing iodide production capacity of 4,100 tons per year [1] - There is an additional project in the trial production stage with a capacity of 4,000 tons per year [1]

Core Insights - The company has recognized the application of iodides in the perovskite battery sector and is actively conducting technical research and product development in this area [1] Group 1 - The company is currently advancing its research and development projects related to iodides in perovskite batteries [1] - No products have been commercialized or sold yet as the R&D projects are still in progress [1]

Group 1: Company Overview - The company, Shandong Boyuan Pharmaceutical Chemical Co., Ltd., has an existing production capacity of 4,100 tons/year for iodide products, with a trial production project of 4,000 tons/year [2] - The main inorganic iodides include potassium iodide, potassium iodate, sodium iodide, hydriodic acid, and cuprous iodide, while the organic iodides include trimethyl iodide and iodomethane [2] Group 2: Applications and Market Distribution - Iodine and its derivatives are crucial raw materials in medical, agricultural, industrial, and nutritional fields, widely used in various product formulations [2] - The major applications of iodine include X-ray contrast agents, biocides, preservatives, pharmaceutical intermediates, LCD and LED screen polarizers, chemicals, organic compounds, and pigments [2] - According to SQM's 2024 annual report, the core application areas of iodine account for approximately 63% of global consumption, with significant production concentrated in Chile, Japan, and the USA, which together account for 88% of global sales [3] Group 3: Financial Performance - The company's net profit decreased year-on-year in the first nine months of 2025, primarily due to rising upstream material prices, which increased product cost pressures [3] Group 4: Production Processes and Innovations - The production of lithium iodide utilizes raw materials such as hydriodic acid, lithium carbonate, formic acid, activated carbon, and lithium hydroxide, involving processes like neutralization, vacuum concentration, cooling crystallization, filtration, and vacuum drying [3] - The company is conducting research and product development on the application of iodides in perovskite batteries, with related R&D projects currently in progress, but no products have been sold as of the report date [3]

1月16日，博苑股份大宗交易成交10万股，成交额849.3万元，占当日总成交额的4.56%，成交价84.93 元，较市场收盘价87.56元折价3%。 | 交易日期 | 证券代码 | 证券简称 | 成交价格 (元) | 成交量 | 成交金额 买方营业部 (万元) | | 卖方营业部 | | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | (万股/万份) | | | | | 2026-01-16 | 301617 | 博苑股份 | 84.93 | 10.00 | 849.30 东兴证券股份有限 | | 中国银河证券股份 | | | | | | | | 公司成都都江堰市 | 有限公司北京金融 | | | | | | | | 彩虹大道证券营业 | 街证券营业部 | | | | | | | | 部 | | | 权益类证券大宗交易(协议交易) | | --- | ...

证券日报网讯 1月14日，博苑股份在互动平台回答投资者提问时表示，截至2026年1月9日，公司股东总 户数为8920户。 （文章来源：证券日报） ...

公司发布的三季报数据显示，前三季公司共实现营业收入10.73亿元，同比增长6.60%，实现净利润1.32 亿元，同比下降22.41%，基本每股收益为0.9912元，加权平均净资产收益率7.93%。（数据宝） （文章来源：证券时报网） 博苑股份1月14日披露，截至2026年1月10日公司股东户数为8920户，较上期（2025年12月31日）减少 472户，环比降幅为5.03%。 证券时报·数据宝统计，截至发稿，博苑股份最新股价为83.98元，下跌0.06%，本期筹码集中以来股价 累计上涨7.99%。具体到各交易日，4次上涨，4次下跌。 融资融券数据显示，该股最新（1月13日）两融余额为1.56亿元，其中，融资余额为1.56亿元，本期筹码 集中以来融资余额合计减少2843.97万元，降幅为15.45%。 ...

（文章来源：每日经济新闻） 每经AI快讯，有投资者在投资者互动平台提问：公司4000吨新项目什么时候可以开始正式生产？ 博苑股份（301617.SZ）1月14日在投资者互动平台表示，公司4000吨/年无机碘化物生产项目正式生产 相关工作正有序推进中，若后续出现达到信息披露标准的节点性进展，公司会及时履行披露义务。 ...

Group 1 - The core viewpoint of the news is that Shandong Boyuan Pharmaceutical Chemical Co., Ltd. has seen a stock price increase of 5.04%, reaching 87.39 yuan per share, with a total market capitalization of 11.679 billion yuan [1] - The company specializes in the research, production, and sales of fine chemicals, including organic iodides, inorganic iodides, precious metal catalysts, luminescent materials, and hexamethyldisilazane, and also engages in resource recycling [1] - The main business revenue composition includes iodides at 74.56%, specialty functional chemicals at 12.79%, trading business at 9.94%, and others at 2.72% [1] Group 2 - Among the top circulating shareholders of Boyuan, Penghua Fund has a fund, Penghua Huizhi Optimal Mixed A, which entered the top ten shareholders in the third quarter, holding 434,200 shares, accounting for 1.3% of circulating shares [2] - The fund has a total scale of 3.828 billion yuan, with a year-to-date return of 2.46% and a one-year return of 30.27% [2] - The fund manager Liang Hao has a tenure of 14 years and 181 days, with the best fund return during his tenure being 317.53% [3]